Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Regan, Julie ^a,b   Murphy, Anne ^a   Chiang, Mindy ^b   Mcmahon, Barry P ^a,b   Coughlan, Tara ^a   Walshe, Margaret ^b  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; PLACEBO; ANTIPARKINSON AGENT;

AIRWAY OBSTRUCTION; ASPIRATION PNEUMONIA; BODY WEIGHT LOSS; CLINICAL EFFECTIVENESS; DEHYDRATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ELECTROMYOGRAM; ESOPHAGUS DISEASE; ESOPHAGUS SURGERY; FLUOROSCOPY; HUMAN; MALNUTRITION; MYOTOMY; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TRACHEOSTOMY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UPPER ESOPHAGUS SPHINCTER; X-RAY COMPUTED TOMOGRAPHY; COMPLICATION; DEGLUTITION DISORDERS; DRUG EFFECTS; NEUROLOGIC DISEASE; PHYSIOLOGY; SWALLOWING;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DEGLUTITION; DEGLUTITION DISORDERS; ESOPHAGEAL SPHINCTER, UPPER; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84931277443     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009968.pub2     Document Type: Review

References (65)

1. Ahsan S, Meleca R, Dworkin J. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngology-Head and Neck Surgery 2000;122(5):691-5.
2. Alberty J, Oelerich M, Ludwig K, Hartmann S, Stoll W. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 2000;110(7):1151-6.
3. Alfonsi E, Merlo IM, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, Lozza A, Martignoni E. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment. Journal of Neurology, Neurosurgery, and Psychiatry 2010;81(8):54-60.
4. Aoyagi Y, Tsubahara A, Seki S, Hiraoka T. The trial of lidocaine injection improves the success rate of botulinum toxin injection for dysphagia with upper esophageal sphincter (UES) dysfunction. Dysphagia 2011;26:432-75.
5. Atkinson S, Rees J. Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection. Journal of Otolaryngology 1997;26(4):273-6.
6. Blitzer R, Brin MF. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngology-Head and Neck Surgery 1997;116(3):328-30.
7. Chiu M, Chang Y, Hsiao T. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia 2004;19(1):52-7.
8. di Pede C, Bonsangue V, Marchese Ragona R, Mion M, Masiero S. Cricopharyngeal botulinum toxin injection and rehabilitation in patients with severe oropharyngeal dysphagia from inclusion body myositis. Dysphagia 2013;28:280-335.
9. Dunne J, Hayes M, Cameron D. Botulinum toxin A for cricopharyngeal dystonia. Lancet 1993;342(8870):559.
10. Haapaniemi JJ, Laurikainen EA, Pulkkinen J, Marttila RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001;16(3):171-5.
11. Kelly E, Koszewski I, Jaradeh S, Merati A, Blumin J, Bock J. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. The Annals of Otology, Rhinology, and Laryngology 2013;122(2):100-8.
12. Kim DY, Park CI, Ohn SH, Moon JY, Chang WH, Park SW. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Archives of Physical Medicine and Rehabilitation 2006;87(10):1346-51.
13. Krause E, Schirra J, Gurkov R. Botulinum toxin A treatment of cricopharyngeal dysphagia after subarachnoid haemorrhage. Dysphagia 2008;23:406-10.
14. Lee SY, Seo HG, Paik NJ. Botulinum toxin injection for dysphagia: a blinded retrospective videofluoroscopic swallowing study analysis. American Journal of Physical Medicine and Rehabilitation 2009;88(6):491-4.
15. Liu L, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Canadian Journal of Gastroenterology 2004;18(6):397-9.
16. Masiero S, Briani C, Marchese-Ragona R, Giacometti P, Costantini M, Zaninotto G. Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation. Journal of Rehabilitation Medicine 2006;38(3):201-3.
17. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. American Journal of Otolaryngology 2005;26(3):157-62.
18. Parameswaran MS, Soliman AM. Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Annals of Otology, Rhinology and Laryngology 2002;111(10):871-4.
19. Rees C, French C, Butler S, Hickman M, Wright S. Cricopharyngeal botulinum toxin injection with dilation for globus pharyngeus. Dysphagia (Dysphagia Research Society Conference, 2010) 2010;25:354-98.
20. Restivo DA, Marchese-Ragona R, Lauria G, Squatrito S, Gullo D, Vigneri R. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Diabetes Care 2006;29(12):2650-3.
21. Restivo DA, Marchese-Ragona R, Patti F, Solaro C, Maimone D, Zappalá G, et al.Botulinum toxin improves dysphagia associated with multiple sclerosis. European Journal of Neurology 2011;18(3):486-90.
22. Restivo D, Casabona A, Nicotra A, Zappia M, Elia M, Romano M, et al.ALS dysphagia pathophysiology Differential botulinum toxin response. Neurology 2013;80(7):616-20.
23. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. The Annals of Otology, Rhinology, and Laryngology 1994;103(1):31-5.
24. Shaw G, Searl J. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001;16:161-7.
25. Sjogren. European Society of Swallowing Disorders. 2011.
26. Terre R, Valles M, Panades A, Mearin F. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: A pilot study. Scandinavian Journal of Gastroenterology 2008;43:1296-303.
27. Terré R, Panadés A, Mearin F. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke. Neurogastroenterology and Motility 2013;24(11):896-e702.
28. Woisard-Bassols V, Alshehri S, Simonetta-Moreau M. The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness. European Archives of Oto-Rhino-Laryngology 2013;270(3):805-15.
29. Zaninotto G, Marchese Ragona R, Briani C, Costantini M, Rizzetto C, Portale G. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. Journal of Gastrointestinal Surgery 2004;8(8):997-1006.
30. Alfonsi E, Merlo I, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, et al.An electrophysiological approach to the diagnosis of neurogenic dysphagia; implications for botulinum toxin treatment. Journal of Neurology, Neurosurgery, and Psychiatry 2010;81(1):54-60.
31. Ali GN, Wallace KL, Schwartz R, DeCarle DJ, Zagami AS, Cook IJ. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology 1996;110(2):383-92.
32. Bian RX, Choi IS, Kim JH, Han JY, Lee SG. Impaired opening of the upper esophageal sphincter in patients with medullary infarctions. Dysphagia 2009;24(2):238-45.
33. Butler SG, Stuart A, Castell D, Russell GB, Koch K, Kemp S. Effects of age, gender, bolus condition, viscosity, and volume on pharyngeal and upper esophageal sphincter pressure and temporal measurements during swallowing. Journal of Speech Language and Hearing Research 2009;52(1):240.
34. Colton-Hudson A, Koopman WJ, Moosa T, Smith D, Bach D, Nicolle M. A prospective assessment of the characteristics of dysphagia in myasthenia gravis. Dysphagia 2002;17(2):147-51.
35. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:698-702.
36. Cook IJ, Dodds WJ, Dantas RO, Massey B, Kern MK, Lang IM, et al.Opening mechanisms of the human upper esophageal sphincter. American Journal of Physiology 1989;257(5 pt 1):G748-59.
37. Cook IJ. Diagnosis and management of cricopharyngeal achalasia and other upper esophageal sphincter opening disorders. Current Gastroenterology Reports 2000;2:191-5.
38. Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, et al.Botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004315.pub2]
39. Ertekin C, Aydogdu I. Electromyography of human cricopharyngeal muscle of the upper esophageal sphincter. Muscle & Nerve 2002;26(6):729-39.
40. Fuster Torres MA, Aytes LB, Escoda CG. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Medicina Oral Patologia Oral Y Cirugia Bucal 2007;12(7):E511-7.
41. Hatlebakk JG, Castell JA, Spiegel J, Paoletti V, Katz PO, Castell DO. Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction-manometric and symptomatic response. Diseases of the Esophagus 1998;11(4):254-9.
42. Heinen F, Molenaers G, Fairhurst C, Carr L, Desloovere K, et al.European consensus table 2006 for botulinum toxin for children with cerebral palsy. European Journal of Paediatric Neurology 2006;10:215-25.
43. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
44. Higo R, Tayama N, Watanabe T, Niimi S. Abnormal elevation of resting pressure at the upper esophageal sphincter of Parkinson's disease patients. European Archives of Otorhinolaryngology 2001;258:552-6.
45. Higo R, Tayama N, Watanabe T, Nitou T. Videomanofluorometric study in amyotrophic lateral sclerosis. Laryngoscope 2002;112(5):911-7.
46. Hiss SG, Huckabee ML. Timing of pharyngeal and upper esophageal sphincter pressures as a function of normal and effortful swallowing in young healthy adults. Dysphagia 2005;20(2):149-56.
47. Hu HT, Shin JH, Kim JH, Park JH, Sung KB, Song HY. Fluoroscopically guided balloon dilation for pharyngoesophageal stricture after radiation therapy in patients with head and neck cancer. American Journal of Roentgenology 2010;194(4):1131.
48. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. The New England Journal of Medicine 1991;324:1186-94.
49. Kahrilas P, Logemann J, Krugler C, Flanagan E. Volitional augmentation of upper esophageal sphincter opening during swallowing. American Journal of Physiology 1991;260:G450-6.
50. Kelly JH. Management of upper esophageal sphincter disorders: indications and complications of myotomy. American Journal of Medicine 2000;108 Suppl 4a:43S-6S.
51. Kos MP, David EF, Klinkenberg-Knol EC, Mahieu HF. Long-term results of external upper esophageal sphincter myotomy for oropharyngeal dysphagia. Dysphagia 2010;25(3):169-76.
52. Leow L, Huckabee ML, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson's disease as measured by the Swallowing Quality of Life (SWAL-QOL) Questionnaire. Dysphagia 2010;25(2):216-20.
53. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005;36(12):2756.
54. McCulloch TM, Hoffman MR, Ciucci MR. High-resolution manometry of pharyngeal swallow pressure events associated with head turn and chin tuck. The Annals of Otology, Rhinology, and Laryngology 2010;119(6):369.
55. Moerman MB. Cricopharyngeal botox injection: indications and technique. Current Opinion in Otolaryngology & Head and Neck Surgery 2006;14(6):431-6.
56. Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. American Journal of Physical Medicine & Rehabilitation 2008;87(11):883.
57. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. The New England Journal of Medicine 2002;346(15):1174-5.
58. Shaker R, Kern M, Bardan E, Taylor A, Stewart ET, Hoffman RG, et al.Augmentation of deglutitive upper esophageal sphincter opening in the elderly by exercise. American Journal of Physiology 1997;272:G1518-22.
59. Shaker R, Easterling C, Kern M, Nitschke T, Massey B, Daniels S, et al.Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology 2002;122(5):1314-21.
60. Singh S, Hamdy S. The upper oesophageal sphincter. Neurogastroenterology & Motility 2005;17:3-12.
61. Sivarao DV, Goyal RK. Functional anatomy and physiology of the upper esophageal sphincter. American Journal of Medicine 2000;108(4a):27S-37S.
62. Smithard DG, O'Neill PA, Parks C, Morris J, Wyatt R, England R, et al.Complications and outcome after acute stroke: does dysphagia matter?. Stroke 1996;27:1200-4.
63. Steinhagen V, Grossman A, Benecke R, Walter U. Stroke patients swallowing disturbance pattern relates to brain lesion location in acute stroke patients. Stroke 2009;40:1903-6.
64. Wada S, Tohara H, Lida T, Inoue M, Sato M, Ueda K. Jaw-opening exercise for insufficient opening of upper esophageal sphincter. Archives Physical Medical Rehabilitation 2012;93:1995-9.
65. Zaninotto G, Marchese Ragona R, Briani C, Costantini M, Rizzetto C, Portale G. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. Journal of Gastrointestinal Surgery 2004;8(8):997-1006.